Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT01935908 Withdrawn - Clinical trials for Subarachnoid Hemorrhage

Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study

SPLASH - Pilot
Start date: May 2013
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the feasibility of prospectively enrolling and randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam or not to receive levetiracetam, and documenting in-hospital and follow-up clinical variables.

NCT ID: NCT01935427 Completed - Hemorrhage Clinical Trials

Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume

Start date: September 2013
Phase: N/A
Study type: Observational

This study is designed to validate implementation of the CRI algorithm in the CypherOx CRI system. Healthy human subjects will undergo progressive reduction in central blood volume to the point of hemodynamic instability (defined by a precipitous fall in systolic blood pressure (SBP) below 70 mmHg and/or voluntary subject termination due to discomfort (such as sweating, nausea, or dizziness) to validate the following hypotheses: The CypherOx CRI system will A. Trend intravascular volume changes (hemorrhage) B. Trend stroke volume changes and C. The CRI trend value is not relative to an initial CRI reading, instead it is an actual CRI trend value that does not require calibration or being placed during normal physiological conditions.

NCT ID: NCT01933230 Terminated - Clinical trials for Intracerebral Hemorrhage

Trial of Cooling for Patients With Excel Cryo Cooling System in Intracerebral Hemorrhage (ICH)

CCSICH
Start date: June 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if cooling the neck of patients with ICH decreases brain temperature. In addition, the investigators will determine if the device improves the delivery of oxygen to the brain. A third goal is to determine if cooling the neck lowers intracranial pressure (which is often times high in patients after ICH).

NCT ID: NCT01932060 Recruiting - Clinical trials for Postpartum Hemorrhage

Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

Start date: August 2013
Phase: Phase 3
Study type: Interventional

Although prior dose-finding studies have investigated the optimal bolus dose of oxytocin to initiate adequate uterine tone, it is unclear what oxytocin infusion regimen is required to maintain adequate uterine tone after delivery. The study investigators aim to compare two different infusion rates of oxytocin to assess the optimal infusion regimen for reducing blood loss in women undergoing elective Cesarean delivery.

NCT ID: NCT01931410 Completed - Clinical trials for Postpartum Haemorrhage

The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial

Start date: June 2013
Phase: Phase 4
Study type: Interventional

The investigators hypothesis in this study is that administration of rectal and sublingual misoprostol decreases intrapartum and postpartum haemorrhage.

NCT ID: NCT01920763 Withdrawn - Clinical trials for Intracerebral Hemorrhage

Observational Study of Safety and Outcomes After Minimally Invasive Surgery for Intracerebral Hemorrhage

MiSPACE
Start date: July 2013
Phase: N/A
Study type: Observational

This pilot study will examine the safety and the clinical outcomes after minimally invasive surgery (using a parafascicular technique guided by diffusion-tensor imaging) for intracerebral hemorrhage in patients selected according to evidence-based criteria. The investigators will compare 30 day and 90 day outcomes of patients who have surgery to that predicted by previously reported models for recovery after ICH, and will also describe any surgical complications related to the procedure. The investigators hypothesize that this technique will have the same mortality rate and function outcome, if not better, when compared to the outcomes predicted by previous models.

NCT ID: NCT01918722 Enrolling by invitation - Clinical trials for Intracerebral Hemorrhage

Clinical Re-evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy

Start date: October 2013
Phase: Phase 4
Study type: Interventional

In order to investigate the time window of acute intracerebral hemorrhage(AICH) by "Blood Activating and Stasis Dispersing" therapy and to verify traditional methods if it would influence or enlarge the brain hematoma, test is made by random double-blind controlled. Patients are classified to (0-6h)and (6-72h) teams. Herbs is separated too. The period of the therapy lasts two weeks, and the follow up should last three months. The main indexes are mortality rate, disability rate and the brain hematoma situation. The review is made by the reference to (NIHSS),(GCS) and so on. So, the window time is determined through this test.

NCT ID: NCT01914419 Completed - Clinical trials for Postpartum Hemorrhage

Oxytocin Via Intramuscular Injection and Intravenous Bolus or Infusion for Prevention of Postpartum Hemorrhage

Start date: April 2014
Phase: N/A
Study type: Interventional

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via intravenous (IV) infusion or IV bolus reduces the rate of postpartum hemorrhage compared to intramuscular (IM) injection.

NCT ID: NCT01910675 Withdrawn - Clinical trials for Postpartum Haemorrhage

PCC and Fibrinogen Compared With FFP in PPH

Start date: July 2013
Phase: Phase 4
Study type: Interventional

The purpose of the study is to find out if the regimen of prothrombin complex concentrate (PCC) together with fibrinogen concentrate is as efficient as fresh frozen plasma (FFP) (plus fibrinogen if needed) during the early stages of the transfusion therapy in postpartum haemorrhage (PPH). The original protocol included the use of HES and the recruitment of patients was postponed while waiting the final decision by EMA. All HES solutions were abandoned at our institution in September and an amendment was made to change the protocol. HES solution are replaced by the use of hyperoncotic (20%) albumin.

NCT ID: NCT01908738 Completed - Clinical trials for Abnormal Uterine Bleeding

Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy

Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this study to determine effectiveness of paracervical block, lidocaine spray and only oral analgesic drugs for pain relief during endometrial biopsy.